Literature DB >> 23392387

Experimental study on low-detection limit for immunomagnetic reduction assays by manipulating reagent entities.

S Y Yang1, C C Yang, H E Horng, B Y Shih, J J Chieh, C Y Hong, H C Yang.   

Abstract

The low limit of detection (LLD) plays an important role in biomolecular assays, especially for early-stage assays. Biomolecular detections usually involve the use of two main elements: a reagent and an analyzer, which both greatly contribute to the LLD. In this work, the relationships among the LLD and reagent-related factors are investigated. The to-be-detected biomolecule is c-reactive protein (CRP) as an example. The assay method is immunomagnetic reduction (IMR). The components of reagent are Fe(3)O(4) magnetic nanoparticles bio-functionalized with antibodies against CRP, dispersed in pH-7.4 phosphate buffered saline solution. Several key factors of the reagent, such as particle concentration, volume ratio of reagent to sample, and particle size, are manipulated to optimize the LLD of detecting CRP.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23392387     DOI: 10.1109/TNB.2013.2240009

Source DB:  PubMed          Journal:  IEEE Trans Nanobioscience        ISSN: 1536-1241            Impact factor:   2.935


  8 in total

1.  Assaying Carcinoembryonic Antigens by Normalized Saturation Magnetization.

Authors:  Jen-Jie Chieh; Kai-Wen Huang; Jin-Cheng Shi; Ming-Hsien Chiang
Journal:  Nanoscale Res Lett       Date:  2015-07-03       Impact factor: 4.703

2.  Magnetic Clustering Effect during the Association of Biofunctionalized Magnetic Nanoparticles with Biomarkers.

Authors:  Kuen-Lin Chen; Jean-Hong Chen; Su-Hsien Liao; Jen-Je Chieh; Herng-Er Horng; Li-Min Wang; Hong-Chang Yang
Journal:  PLoS One       Date:  2015-08-13       Impact factor: 3.240

3.  Bio-functionalized magnetic nanoparticles for the immunoassay of fetal fibronectin: a feasibility study for the prediction of preterm birth.

Authors:  Chian-Huey Wong; Chie-Pein Chen; Chia-Chen Chang; Chen-Yu Chen
Journal:  Sci Rep       Date:  2017-02-15       Impact factor: 4.379

4.  Plasma Tau Levels in Cognitively Normal Middle-Aged and Older Adults.

Authors:  Ming-Jang Chiu; Ling-Yun Fan; Ta-Fu Chen; Ya-Fang Chen; Jen-Jei Chieh; Herng-Er Horng
Journal:  Front Aging Neurosci       Date:  2017-03-06       Impact factor: 5.750

5.  Plasma Aβ analysis using magnetically-labeled immunoassays and PET 18F-florbetapir binding in non-demented patients with major depressive disorder.

Authors:  Kuan-Yi Wu; Ing-Tsung Hsiao; Chia-Hsiang Chen; Chia-Yih Liu; Jung-Lung Hsu; Sheng-Yao Huang; Tzu-Chen Yen; Kun-Ju Lin
Journal:  Sci Rep       Date:  2018-02-09       Impact factor: 4.379

6.  Use of immunomagnetic reduction for C-reactive protein assay in clinical samples.

Authors:  Chien-Hsi Chang; Zhi-Xian Lai; Hsiu-Li Lin; Che-Chuan Yang; Hsin-Hsien Chen; Shieh-Yueh Yang; Herng-Er Horng; Chin-Yih Hong; Hong-Chang Yang; Hsiu-Chen Lin
Journal:  Int J Nanomedicine       Date:  2012-08-06

7.  Characterizations of Anti-Alpha-Fetoprotein-Conjugated Magnetic Nanoparticles Associated with Alpha-Fetoprotein for Biomedical Applications.

Authors:  Shu-Hsien Liao; Han-Sheng Huang; Jen-Jie Chieh; Yu-Kai Su; Yuan-Fu Tong; Kai-Wen Huang
Journal:  Sensors (Basel)       Date:  2017-09-03       Impact factor: 3.576

8.  Validation of Assaying Carcinoembryonic Antigen in Human Serum by Using Immunomagnetic Reduction.

Authors:  Po-Li Wei; Long-Teng Lee; Li-Ming Tseng; Kai-Wen Huang
Journal:  Sci Rep       Date:  2018-07-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.